Literature DB >> 7179198

Toxicity of high-dose intrapleural BCG.

J A Bennett, M F McKneally.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7179198      PMCID： PMC459395          DOI： 10.1136/thx.37.8.640

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  5 in total

1.  Adjuvant immunotherapy with BCG in squamous cell bronchial carcinoma.

Authors:  H M Jansen; T H The; N G Orie
Journal:  Thorax       Date:  1980-10       Impact factor: 9.139

2.  Four-year follow-up on the Albany experience with intrapleural BCG in lung cancer.

Authors:  M F McKneally; C Maver; L Lininger; H W Kausel; J B McIlduff; T M Older; E D Foster; R D Alley
Journal:  J Thorac Cardiovasc Surg       Date:  1981-04       Impact factor: 5.209

3.  Complications of postoperative intrapleural BCG in lung cancer.

Authors:  W Bakker; J M Nijhuis-Heddes; A Brutel de la Rivière; J H Dijkman
Journal:  Ann Thorac Surg       Date:  1982-03       Impact factor: 4.330

4.  Regional immunotherapy with intrapleural BCG for lung cancer.

Authors:  M F McKneally; C Maver; H W Kausel; R D Alley
Journal:  J Thorac Cardiovasc Surg       Date:  1976-09       Impact factor: 5.209

5.  Postoperative intrapleural BCG in lung cancer: lack of efficacy and possible enhancement of tumour growth.

Authors:  W Bakker; J M Nijhuis-Heddes; A M Wever; A Brutel de la Rivière; E A van der Velde; J H Dijkman
Journal:  Thorax       Date:  1981-11       Impact factor: 9.139
  5 in total
  1 in total

1.  Post-operative intrapleural BCG in lung cancer: a 5-year follow-up report.

Authors:  W Bakker; J M Nijhuis-Heddes; E A van der Velde
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.